Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remicade for Prevention of Crohn's Disease Recurrence After Surgery
NCT01190839Phase 3Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2010
- Primary completion
- Dec 2014
- Countries
- 14
01
Overview
A Phase 3 trial of infliximab in Crohn's disease, sponsored by Janssen Pharmaceutical. Started Nov 2010; status: terminated.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01190839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01190839.